WOLFGANG WINKELMAYER to Cyclosporine
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Cyclosporine.
Connection Strength
0.434
-
A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes. PLoS One. 2019; 14(7):e0218709.
Score: 0.156
-
Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial. PLoS One. 2015; 10(8):e0135674.
Score: 0.119
-
Effect of conversion from ciclosporin to tacrolimus on endothelial progenitor cells in stable long-term kidney transplant recipients. Transplantation. 2013 Jun 15; 95(11):1338-45.
Score: 0.103
-
Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction. Clin Transplant. 2004 Aug; 18(4):341-8.
Score: 0.056